Abstract

Many microbial producers of coenzyme B12 family cofactors together with their metabolically interdependent pathways are comprehensively studied and successfully used both in natural ecosystems dominated by auxotrophs, including bacteria and mammals, and in the safe industrial production of vitamin B12. Metabolic reconstruction for genomic and metagenomic data and functional genomics continue to mine the microbial and genetic resources for biosynthesis of the vital vitamin B12. Availability of metabolic engineering techniques and usage of affordable and renewable sources allowed improving bioprocess of vitamins, providing a positive impact on both economics and environment. The commercial production of vitamin B12 is mainly achieved through the use of the two major industrial strains, Propionobacterium shermanii and Pseudomonas denitrificans, that involves about 30 enzymatic steps in the biosynthesis of cobalamin and completely replaces chemical synthesis. However, there are still unresolved issues in cobalamin biosynthesis that need to be elucidated for future bioprocess improvements. In the present work, we review the current state of development and challenges for cobalamin (vitamin B12) biosynthesis, describing the major and novel prospective strains, and the studies of environmental factors and genetic tools effecting on the fermentation process are reported.

Highlights

  • Vitamin B12 is an important nutrient for humans and animals, which plays a key coenzyme role in numerous mitochondrial and cytosolic pathways, methylation-mediated regulation, and regulation of sex steroids due to the host–microbe metabolic interactions, it is essential for gut microbiota themselves [1,2]

  • Among the hundred cyanobacteria genomes screened for the B12 biosynthetic genes, including those involved in the nucleotide loop assembly, pseudocobalamin is the form synthesized by cyanobacteria more broadly

  • The gut microbes have been suggested to be under reductive genomic evolution, driven by genetic drift, which is common in endosymbiotic bacteria and states that fitness gain accompanying gene loss is frequency dependent, demanding the B-vitamin donors must remain in sufficient abundance in communities to ensure that auxotrophs are not subject to negative selection [83]

Read more

Summary

Introduction

Vitamin B12 is an important nutrient for humans and animals, which plays a key coenzyme role in numerous mitochondrial and cytosolic pathways (tricarboxylic acid cycle, one-carbon metabolism including methionine and folate cycles), methylation-mediated regulation (metabolites, DNA, RNA, and proteins), and regulation of sex steroids due to the host–microbe metabolic interactions, it is essential for gut microbiota themselves [1,2]. It is widely used as a dietary supplement, as medicine for treating hematologic and neurological disorders, and as important feed additives (growth enhancer) for fowls and domestic animals. We describe the microbial vitamin B12 synthesis and variations of metabolic pathways, as well as their abundance and auxotrophy in various ecosystems, providing characteristics of strategies that were applied to enhancement of cobalamin production on the lab and industrial scale

An Overview of Cobalamin Biosynthesis
Historical Implication of Cobalamin Biosynthesis Signatures
Aerobic Pathway and Related Enzymes
Anaerobic Pathway and Related Enzymes
Common Pathway and Salvage
Selectivity of Lower Ligand Activation
Chromosomal Organization of Cobalamin Biosynthesis Pathways
Clusters and Operons in Anaerobic Pathway
Clusters and Operons in Aerobic Pathway
Transport Systems in Bacteria
Genetic Signatures of Cobalamin Pathways and Transport
Metabolic Reconstruction Methods
Cobamide Uptake in Eukaryotes
Cobalamin-Dependent Metabolism
Riboswitch Structure and Mechanism of Regulation
Riboswitch-Encoding Sequences Location and Function
Ligand Selectivity of Riboswitches
Light-Dependent Regulation
Marine Microbial Community Auxotrophy
Gut Microbial Community Auxothrophy
Evolutionary Strategy for Cosmopolite Bacteria Auxothrophy
Mammalian B12 Auxotrophy
Discovery and Development of Biotechnological B12 Producers
Propionobacteria
Pseudomonades
Bacillus megaterium
Escherichia coli
Other Microorganisms
Industrial Bioprocess of Vitamin B12
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.